Detailed characterization of Humanin, a newly identified anti-Alzheimer's disease peptide and potential starting point for development of the first curative therapy for Alzheimer's disease

护脑素(一种新发现的抗阿尔茨海默病肽)的详细表征以及开发第一种阿尔茨海默病治疗方法的潜在起点

基本信息

  • 批准号:
    13307022
  • 负责人:
  • 金额:
    $ 35.44万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
  • 财政年份:
    2001
  • 资助国家:
    日本
  • 起止时间:
    2001 至 2002
  • 项目状态:
    已结题

项目摘要

No fundamental therapy for Alzheimer's disease (AD) has so far been developed. Humanin is a newly identified peptide that suppresses cell death by Alzheimer's disease (AD)-related insults. We have investigated the structure/function relationship for the neuroprotective function of HN peptide. When either Pro3, Ser7, Cys8, Leu9, Leu 12, Thr13, Ser14, or Pro19 is changed to Ala in full-length HN, the HN derivatives lose its neuroprotective activity. Pro3-Pro19 turned out to be the core domain for neuroprotection by HN. HN forms a homodimer, which is essential for HN neuroprotection, and that Ala substitution for Ser7 or Leu9 nullifies homodimerization by HN. HN should be secreted and be able to act from the outside, indicating that a certain cell-surface receptor is the target of HN. HN immunoreactivity is detected in some of the intact large neurons in the occipital lobe of an AD brain, but not in other brain regions or in an age-matched control brain. In mice, 3 kDa immunoreactive pept … More ide, the deduced molecular weight of HN, has been detected in the testes and colons of 3-week-old mice. This immunoreactivity disappears in the colon of 12-week-old mice, pointing to the age-dependent regulation of HN production. We identified TRIM11 as a HN-interacting protein, a member of a protein family containing a tripartite motif (TRIM). TRIM11 is composed of a RING finger domain, which is a putative E3 ubiquitin ligase. Notably, TRIM11 ubiquitinizes and degrades HN intracellularly. We also found that the potentiation of HN neuroprotective function by Gly substitution for Ser14 is specifically mimicked by D-Ser isomerization. Therefore, it is conceivable that HN peptide is transcribed and translated from the HN gene and then converted to the maximally active form by posttranslational modification at Ser14, that is, D-Ser14 isomerization. Considering that insulin-like growth factor-binding protein 3 is an HN-binding protein in the blood [20], it is an attractive hypothesis that HN is mainly produced in tissues outside the central nervous system (CNS), transferred by binding to the binding protein, and further activated as it passes through the blood-brain barrier, and is delivered to CNS neurons. Considering the broad specificity of its rescue activity to AD-relevant insults, HN is a promising seed for AD therapy aiming the complete suppression of neuronal loss. Less
到目前为止,还没有开发出针对阿尔茨海默病(AD)的基本疗法。Humanin是一种新发现的抑制阿尔茨海默病(AD)相关损伤引起的细胞死亡的肽。我们研究了HN肽神经保护功能的结构/功能关系。当全长HN中的Pro 3、Ser 7、Cys 8、Leu 9、Leu 12、Thr 13、Ser 14或Pro 19变为Ala时,HN衍生物失去其神经保护活性。Pro3-Pro19是HN神经保护作用的核心结构域。HN形成同源二聚体,这是HN神经保护所必需的,并且Ala取代Ser7或Leu9使HN的同源二聚化无效。HN应该是分泌的,并且能够从外部起作用,这表明某种细胞表面受体是HN的靶点。HN免疫反应性在AD脑枕叶中的一些完整的大神经元中检测到,但在其他脑区域或年龄匹配的对照脑中未检测到。在小鼠中,3kDa免疫反应性肽 ...更多信息 已在3周龄小鼠的睾丸和结肠中检测到HN的推断分子量ide。这种免疫反应性在12周龄小鼠的结肠中消失,表明HN产生的年龄依赖性调节。我们确定TRIM11作为HN相互作用蛋白,一个成员的蛋白质家族包含一个三重基序(TRIM)。TRIM11由RING指结构域组成,其是推定的E3泛素连接酶。值得注意的是,TRIM11在细胞内泛素化并降解HN。我们还发现,通过Gly取代Ser14增强HN神经保护功能是通过D-Ser异构化特异性模仿的。因此,可以想象HN肽从HN基因转录和翻译,然后通过Ser 14处的翻译后修饰,即D-Ser 14异构化,转化为最大活性形式。考虑到胰岛素样生长因子结合蛋白3是血液中的HN结合蛋白[20],HN主要在中枢神经系统(CNS)外的组织中产生,通过结合结合蛋白转移,并在穿过血脑屏障时进一步活化,并递送至CNS神经元,这是一个有吸引力的假设。考虑到其对AD相关损伤的广泛特异性拯救活性,HN是一种有希望的AD治疗种子,旨在完全抑制神经元损失。少

项目成果

期刊论文数量(28)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Hashimoto Y et al.: "Mechanisms of neuroprotection by a novel rescue factor Humanin from Swedish mutant amyloid precursor protein"Biochemical and Biophysical Research Communications. 283. 460-468 (2001)
Hashimoto Y 等人:“来自瑞典突变淀粉样前体蛋白的新型救援因子护脑素的神经保护机制”生物化学和生物物理研究通讯。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Identification of essential amino acids in Humanin, a neuroprotective factor against Alzheimer’s disease-relevant insults
  • DOI:
    10.1016/s0196-9781(03)00106-2
  • 发表时间:
    2003-04
  • 期刊:
  • 影响因子:
    3
  • 作者:
    Y. Yamagishi;Y. Hashimoto;T. Niikura;I. Nishimoto
  • 通讯作者:
    Y. Yamagishi;Y. Hashimoto;T. Niikura;I. Nishimoto
Hashimoto Y et al.: "Detailed characterization of neuroprotection by a rescue factor Humanin against various Alzheimer's disease-relevant insults"Journal of Neuroscience. 21. 9235-9245 (2001)
Hashimoto Y 等人:“救援因子护脑素针对各种阿尔茨海默病相关损伤的神经保护的详细表征”《神经科学杂志》。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Hashimoto Y et al.: "A rescue factor abolishing neuronal cell death by a wide spectrum of familial Alzheimer's disease genes and Aβ"Proceedings of the National Academy of Sciences of the United States of America. 98. 6336-6341 (2001)
Hashimoto Y 等人:“通过广泛的家族性阿尔茨海默病基因和 Aβ 消除神经元细胞死亡的拯救因子”美国国家科学院院刊 98. 6336-6341 (2001)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Niikura T et al.: "A tripartite motif protein, binds and destabilizes Humanin, a neuroprotective peptide against Alzheimer's disease-relevant insults"European Journal of Neuroscience. (in press). (2003)
Niikura T 等人:“一种三联基序蛋白,与护脑素结合并使其不稳定,护脑素是一种针对阿尔茨海默病相关损伤的神经保护肽”《欧洲神经科学杂志》。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

NISHIMOTO Ikuo其他文献

NISHIMOTO Ikuo的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('NISHIMOTO Ikuo', 18)}}的其他基金

Elucidation of the principal mechanism for dementia and identification of anti-dementia genes through the analysis of ApoE4 neurotoxicity
通过ApoE4神经毒性分析阐明痴呆的主要机制并鉴定抗痴呆基因
  • 批准号:
    11307011
  • 财政年份:
    1999
  • 资助金额:
    $ 35.44万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Comprehensive analysis of hetrotrimeric G protein subunits for the purpose of elucidation and treatment of human diseases
综合分析异源三聚体 G 蛋白亚基,以阐明和治疗人类疾病
  • 批准号:
    09307002
  • 财政年份:
    1997
  • 资助金额:
    $ 35.44万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A).
Elucidation of molecular mechanisms for cell death in neurodegenerative diseases and extensive research of their antagonists
阐明神经退行性疾病细胞死亡的分子机制及其拮抗剂的广泛研究
  • 批准号:
    09357005
  • 财政年份:
    1997
  • 资助金额:
    $ 35.44万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A).

相似国自然基金

新型F-18标记香豆素衍生物PET探针的研制及靶向Alzheimer's Disease 斑块显像研究
  • 批准号:
    81000622
  • 批准年份:
    2010
  • 资助金额:
    20.0 万元
  • 项目类别:
    青年科学基金项目
阿尔茨海默病(Alzheimer's disease,AD)动物模型构建的分子机理研究
  • 批准号:
    31060293
  • 批准年份:
    2010
  • 资助金额:
    26.0 万元
  • 项目类别:
    地区科学基金项目
跨膜转运蛋白21(TMP21)对引起阿尔茨海默病(Alzheimer'S Disease)的γ分泌酶的作用研究
  • 批准号:
    30960334
  • 批准年份:
    2009
  • 资助金额:
    22.0 万元
  • 项目类别:
    地区科学基金项目

相似海外基金

Discovering early biomarkers of Alzheimer's disease using genetic and physics-informed networks
利用遗传和物理信息网络发现阿尔茨海默病的早期生物标志物
  • 批准号:
    2904538
  • 财政年份:
    2024
  • 资助金额:
    $ 35.44万
  • 项目类别:
    Studentship
Deciphering electrophysiological Alzheimer's Disease biomarkers for early diagnosis using interpretable deep learning
使用可解释的深度学习破译电生理阿尔茨海默病生物标志物以进行早期诊断
  • 批准号:
    24K18602
  • 财政年份:
    2024
  • 资助金额:
    $ 35.44万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Investigating And Targeting Microglial Senescence In Alzheimer's Disease
研究并针对阿尔茨海默病中的小胶质细胞衰老
  • 批准号:
    MR/Y004116/1
  • 财政年份:
    2024
  • 资助金额:
    $ 35.44万
  • 项目类别:
    Research Grant
DMS/NIGMS 1: Multilevel stochastic orthogonal subspace transformations for robust machine learning with applications to biomedical data and Alzheimer's disease subtyping
DMS/NIGMS 1:多级随机正交子空间变换,用于稳健的机器学习,应用于生物医学数据和阿尔茨海默病亚型分析
  • 批准号:
    2347698
  • 财政年份:
    2024
  • 资助金额:
    $ 35.44万
  • 项目类别:
    Continuing Grant
Histone variant macroH2A1 as a novel regulator of memory deficits in Alzheimer's disease
组蛋白变体 MacroH2A1 作为阿尔茨海默病记忆缺陷的新型调节剂
  • 批准号:
    478226
  • 财政年份:
    2023
  • 资助金额:
    $ 35.44万
  • 项目类别:
    Operating Grants
Incorporating Diversity in Alzheimer's Disease Research: Developing Representative and Generalizable models
将多样性纳入阿尔茨海默病研究:开发代表性和可推广的模型
  • 批准号:
    495662
  • 财政年份:
    2023
  • 资助金额:
    $ 35.44万
  • 项目类别:
    Operating Grants
Development of novel macrocyclic BACE1 inhibitors for preventive or therapeutic agents for Alzheimer's disease
开发用于预防或治疗阿尔茨海默病的新型大环 BACE1 抑制剂
  • 批准号:
    23K06058
  • 财政年份:
    2023
  • 资助金额:
    $ 35.44万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Fluency from Flesh to Filament: Collation, Representation, and Analysis of Multi-Scale Neuroimaging data to Characterize and Diagnose Alzheimer's Disease
从肉体到细丝的流畅性:多尺度神经影像数据的整理、表示和分析,以表征和诊断阿尔茨海默病
  • 批准号:
    10462257
  • 财政年份:
    2023
  • 资助金额:
    $ 35.44万
  • 项目类别:
Computational modelling of disease progression and subtype discovery in Alzheimer's Disease
阿尔茨海默病疾病进展和亚型发现的计算模型
  • 批准号:
    2885305
  • 财政年份:
    2023
  • 资助金额:
    $ 35.44万
  • 项目类别:
    Studentship
The Contribution of Mitochondrial Dysfunction to Alzheimer's disease
线粒体功能障碍对阿尔茨海默病的影响
  • 批准号:
    2886872
  • 财政年份:
    2023
  • 资助金额:
    $ 35.44万
  • 项目类别:
    Studentship
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了